Delivery Order SPE2DB20D2001-SPE2DB25FPNMM
Award Date 8/19/25
Potential Completion Date 8/20/25
Potential Value $1.1K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Bupropion HCL XL 450 mg tablets (30-count) valued at $1,278.64. This non-set-aside, firm fixed-price delivery order was awarded on July 14, 2025, with an ultimate completion date of July 15, 2025. The product will be delivered to the company's corporate office location in Conshohocken, Pennsylvania, which serves as AmerisourceBergen's headquarters and primary distribution point for federal...
- On August 14, 2025, the Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp for Bupropion HCL XL 150 mg tablets (100 unit dose packages) with a ceiling value of $2,472.49. This is a firm fixed price, non-set-aside contract with an ultimate completion date of August 15, 2025, and performance to be executed from the contractor's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's larger...
- The Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the delivery of 500 tablets of Bupropion HCL XL 150 mg. The contract has a total potential value of $2,209.29 and a completion date of February 8, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) held by Amerisourcebergen Drug Corp with DLA, valued at up to $999,999,999.00 and running through...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of the global pharmaceutical distribution company AmerisourceBergen Corporation. The delivery order, valued at $12,723.06, is for the supply of 4,564,083,598 units of Bupropion HCL XL 150 mg tablets to DLA Troop Support Medical facilities supporting the Department of Defense. The delivery order falls under a larger indefinite delivery contract (IDC) awarded...
- This is a $23,858.03 firm-fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The order is for 4,564,296,807 units of Bupropion HCL XL 150 mg tablets with a completion date of April 17, 2024. Amerisourcebergen is a major supplier of pharmaceuticals and medical supplies to the U.S. federal government, particularly the Department of Defense (DoD) and Department of Veterans Affairs (VA) healthcare...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,539.90 firm fixed-price delivery order is for the supply of 500 count BUPROPION HCL XL 150 MG tablets. The contract has an ultimate completion date of January 18, 2024. AmerisourceBergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $22,732.67 firm-fixed-price delivery order is for the supply of 4,562,816,824 units of Bupropion HCL XL 150 mg tablets. The award has an ultimate completion date of November 15, 2023. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA...
- The Defense Logistics Agency (DLA) awarded Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a firm fixed price delivery order contract to provide 500 units of BUPROPION HCL XL 300 MG TABLET. The contract has a total potential value of $5,376.14 and a completion date of February 5, 2024. This delivery order is issued under a larger indefinite delivery contract (IDC) awarded by DLA to Amerisourcebergen Drug Corp, valued at up to $999,999,999.00, to provide a...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Bupropion HCL XL 300 mg tablets (500 count) with a ceiling value of $13,236.86. The contract is a firm fixed price delivery order with an ultimate completion date of September 15, 2025, and was competitively awarded without set-aside restrictions. Performance will be executed from the contractor's location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The $1,598.98 firm fixed price delivery order is for the supply of 4,563,970,057 units of the prescription medication Bupropion HCL XL 150 mg tablets. The contract has an ultimate completion date of March 15, 2024. Amerisourcebergen Drug Corp is the prime contractor on an indefinite delivery contract (IDC) with DLA, valued at up to...